Neuromuscular blockade with acute respiratory failure in a patient receiving cibenzoline

Thorax

Volumn 52, Issue 6, 1997, Pages 582-584

  Similowski, Thomas ^a   Straus, Christian ^a   Attali, Valérie ^a   Girard, Frédéric ^a   Philippe, François ^a   Deray, Gilbert ^a   Thomas, Daniel ^a   Derenne, Jean Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Acute respiratory failure; Cibenzoline; Diaphragm paralysis; Neuromuscular blockade; Phrenic nerve stimulation

Indexed keywords

CIBENZOLINE;

ACUTE RESPIRATORY FAILURE; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BRADYCARDIA; CASE REPORT; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; KIDNEY FAILURE; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

EID: 0030754026     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.6.582     Document Type: Article

References (16)

1. Aldrich TK, Prezant DJ. Adverse effects of drugs on the respiratory muscles. Clin Chest Med 199011:177-89
2. Eriksson LI. Ventilation and neuromuscular blocking drugs. Acta Anaesthesiol Scand Suppl 1994;102:11-5.
3. Harron DW, Brogden RN, Faulds D, Fitton A. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias. Drugs 1992;43:734-59.
4. Hilleman DE, Mohiuddin SM, Ahmed IS, Dahl JM. Cibenzoline-induced hypoglycemia. Drug Intell Clin Pharm 1987;21:38-40.
5. Delhez L, Modalités, chez l'homme normal, de la réponse électrique des piliers du diaphragme à la stimulation électrique des nerfs phréniques par des chocs uniques. Arch Int Physiol Biochim 1965;73:832-9.
6. Mier A, Brophy C, Moxham J, Green M. Repetitive stimulation of phrenic nerves in myasthenia gravis. Thorax 1992; 47:640-4.
7. Hamnegard CH, Wragg S, Kyroussis D, Mills G, Bake B, Green M, et al. Mouth pressure in response tu magnetic stimulation of the phrenic nerves. Thorax 1995;50:620-4.
8. Lee DC, Kim YI, Liu HH, Johns TR. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission. Muscle Nerve 1983;6:442-7.
9. Drachman DA, Skom JH. Procainamide: a hazard in myasthenia gravis. Arch Neurol 1965;13-316-20.
10. Hall CD, Malouf N. Skeletal muscle weakness resulting from quinidine ingestion. South Med J 1987;80:403-4.
11. Fontiveros ES, Cumming WJ, Hudgson P. Procainamide-induced myositis. J Neurol Sci 1981;45:143-7.
12. Yagiela JA, Benoit PW. Skeletal-muscle damage from quinidine (letter). N Engl J Med 1979;301:437.
13. Aronoff G, Brier M, Mayer ML, Barbalas M, Aogaichi K, Sloan R, et al. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function. J Clin Pharmacol 1991;31:38-44.
14. Zitko U, Auinger M, Albrecht G, Kastenbauer T, Lahrmann H, Grisold W, et al. Phrenic neuropathy in chronic renal failure. Thorax 1995;50:793-4.
15. Zalman F, Perloff JK, Durant NN, Campion DS. Acute respiratory failure following intravenous verapamil in Duchenne's muscular dystrophy. Am Heart J 1983;105:510-1.
16. Aubier M, Viires N, Piquet J, Murciano D, Blanchet F, Marty C, et al. Effects of hypocalcemia on diaphragmatic strength generation. J Appl Physiol 1985;58:2054-61.